Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis
Arturo B. Ramirez, Meghana V. Trivedi(University of Houston), Carmine De Angelis(Baylor College of Medicine), C. Kent Osborne(Baylor College of Medicine), Rachel Schiff(Baylor College of Medicine), Michael T. Lewis(Baylor College of Medicine), Debashish Sahay(University of Houston), Hariprasad Thangavel(Hackensack Meridian Health), Raksha R. Bhat(University of Houston), Chandandeep Nagi(Icahn School of Medicine at Mount Sinai), Agostina Nardone(AstraZeneca (Spain)), Jackie L. Stilwell(ViaCyte (United States)), Mario Giuliano(Regione Campania), Mothaffar F. Rimawi(Baylor College of Medicine), Sina Hedayatpour(University of Houston), Lacey E. Dobrolecki(Baylor College of Medicine), Eric Kaldjian(Seattle University)
Cited by 24
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
|Endocrine Reviews|2008|545